^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners

    TEST:
    OncoTarget® 500

    Company:
    GoPath Lab
    Type:
    CE Marked
    Related tests:
    Details
    Evidence

    News

    over2years
    GoPath® Diagnostics launches FDA-Cleared CGP Test under OncoTarget® 500 (PRWeb)
    "OncoTarget® 500 assesses cancer pathology by analyzing over 500 genes to detect genetic alterations associated with cancer growth. With OncoTarget® 500, oncologists and researchers may effectively determine the unique genomic profile of individual tumors to determine the most suitable therapies for optimal medical outcomes in a timely manner."
    Launch
    |
    OncoTarget® 500